Expanding Dialogue Between HTA Bodies and Stakeholders
Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact | Cost Effectiveness and Resource Allocation | Full Text
EU HTA Regulation 2021/2282
Level of Patient Involvement in HTA Agencies | Alira Health
Living HTAs: Keeping Health Technology Evidence In Real-Time
Europe's patchwork of evidence requirements is an important factor in delayed patient access - Consultancy in Healthcare and Life Sciences | Vintura Consultancy
Early engagement with Health Technology Assessment authorities will accelerate product launch and improve chances for reimbursement
3. Processes and methods
About EUnetHTA - EUnetHTA
European collaboration between regulators and Health Technology Assessment ( HTA) bodies - YouTube
Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies - ScienceDirect
Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries | PharmacoEconomics - Open
HTA systems in Europe - EUPATI Toolbox
How can a joint European health technology assessment provide an 'additional benefit' over the current standard of national assessments? | Health Economics Review | Full Text
Health Technology Assessment process: Fundamentals - EUPATI Toolbox
Figure 5 from Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland. | Semantic Scholar
Single arm trial submissions to HTA bodies; Globally, 2011-2019. | Download Scientific Diagram